Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank29
5Y CAGR-5.7%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-5.7%/yr
Long-term compound
Percentile
P29
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$521000.00-76.8%
2024$2.24M-8.9%
2023$2.46M-
2022$0.00-
2021$0.00-100.0%
2020$700000.00+158.3%
2019$271000.00+1029.2%
2018$24000.00-100.0%
2017$2.93B+28.5%
2016$2.28B-